{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:33:08Z","timestamp":1793719988771,"version":"4.6.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006452","name":"University of Miyazaki","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006452","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular-kidney-metabolic (CKM) syndrome, integrating cardiovascular disease (CVD), chronic kidney disease (CKD), and metabolic dysfunction, is a construct proposed by the American heart association. Although associations with CVD are well recognized, evidence linking CKM stage to renal outcomes remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We analyzed health checkup data of 266,256 Japanese aged 40\u201374\u00a0years. Participants were classified into CKM stages 0\u20134a. Outcomes included all-cause mortality, cardiovascular death, and a composite renal outcome (end-stage kidney disease [eGFR\u2009&lt;\u200915\u00a0mL\/min\/1.73\u00a0m\n                      <jats:sup>2<\/jats:sup>\n                      ],\u2009\u2265\u200940% eGFR decline, or doubling of serum creatinine). Multivariable Cox proportional hazards models were used to estimate hazard ratios (HRs), with CKM stage 0 as the reference.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CKM stage 2 was the most prevalent stage (65.0%). Stage 4a showed the strongest association with all-cause and cardiovascular mortality (HRs 1.79, 3.16; 95% CIs 1.41\u20132.28, 1.92\u20135.20, respectively). In contrast, stage 3 conferred the highest risk of renal outcomes (HR 15.29, 95% CI 10.13\u201323.08). The number and type of metabolic risk factors correlated with outcomes, furthermore, severe CKD and prior CVD were stronger drivers of adverse outcomes than metabolic dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CKM staging stratifies risk in the general population. No significant increase in risk was observed until CKM stage 2, and these findings underscore the progressive, cumulative nature of CKM syndrome. Metabolic dysfunction plays a crucial role in progression, stage 3 marks a pivotal inflection point for renal deterioration, and stage 4a identifies individuals at the greatest mortality risk. Early interventions targeting metabolic dysfunction may help prevent progression to advanced CKM stages and improve long-term outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10157-025-02800-x","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T09:54:34Z","timestamp":1765965274000},"page":"434-445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Stage-specific risks of mortality and renal outcomes in cardiovascular-kidney-metabolic syndrome: findings from a nationwide Japanese cohort"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4258-3692","authenticated-orcid":false,"given":"Kenta","family":"Fujimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michikazu","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneo","family":"Konta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunitoshi","family":"Iseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Tsuruya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiei","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugo","family":"Shibagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Asahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kaikita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouichi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"2800_CR1","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American heart association. Circulation. 2023;148:1636\u201364. https:\/\/doi.org\/10.1161\/CIR.0000000000001186.","journal-title":"Circulation"},{"key":"2800_CR2","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association. Circulation. 2023;148:1606\u201335. https:\/\/doi.org\/10.1161\/CIR.0000000000001184.","journal-title":"Circulation"},{"key":"2800_CR3","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019. J Am Coll Cardiol. 2020;76:2982\u20133021. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.010.","journal-title":"J Am Coll Cardiol"},{"key":"2800_CR4","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S2213-8587(17)30327-3","volume":"5","author":"K Ueki","year":"2017","unstructured":"Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, Katsuyama H, et al. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial. Lancet Diabetes Endocrinol. 2017;5:951\u201364. https:\/\/doi.org\/10.1016\/S2213-8587(17)30327-3.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2800_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.kint.2020.08.012","volume":"99","author":"K Ueki","year":"2021","unstructured":"Ueki K, Sasako T, Okazaki Y, Miyake K, Nangaku M, Ohashi Y, et al. Multifactorial intervention has a significant effect on diabetic kidney disease in patients with type 2 diabetes. Kidney Int. 2021;99:256\u201366. https:\/\/doi.org\/10.1016\/j.kint.2020.08.012.","journal-title":"Kidney Int"},{"key":"2800_CR6","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","volume":"373","author":"Prospective studies collabouration","year":"2009","unstructured":"Prospective studies collabouration. Body-mass index and cause-specific mortality in 900,000 adults: colLabourative analyses of 57 prospective studies. Lancet. 2009;373:1083\u201396. https:\/\/doi.org\/10.1016\/S0140-6736(09)60318-4.","journal-title":"Lancet"},{"key":"2800_CR7","doi-asserted-by":"publisher","first-page":"e0173515","DOI":"10.1371\/journal.pone.0173515","volume":"12","author":"WG Herrington","year":"2017","unstructured":"Herrington WG, Smith M, Bankhead C, Matsushita K, Stevens S, Holt T, et al. Body-mass index and risk of advanced chronic kidney disease: prospective analyses from a primary care cohort of 1.4 million adults in England. PLoS ONE. 2017;12:e0173515. https:\/\/doi.org\/10.1371\/journal.pone.0173515.","journal-title":"PLoS ONE"},{"key":"2800_CR8","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1007\/s10157-017-1392-y","volume":"21","author":"K Iseki","year":"2017","unstructured":"Iseki K, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, et al. Mortality risk among screened subjects of the specific health check and guidance program in Japan 2008\u20132012. Clin Exp Nephrol. 2017;21:978\u201385. https:\/\/doi.org\/10.1007\/s10157-017-1392-y.","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"2800_CR9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10157-024-02497-4","volume":"28","author":"Japanese society of nephrology office@ jsn. or. jp","year":"2024","unstructured":"Japanese society of nephrology office@ jsn. or. jp. Essential points from evidence-based clinical practice guideline for chronic kidney disease 2023. Clin Exp Nephrol. 2024;28(6):473\u201395. https:\/\/doi.org\/10.1007\/s10157-024-02497-4.","journal-title":"Clin Exp Nephrol"},{"key":"2800_CR10","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392. https:\/\/doi.org\/10.1053\/j.ajkd.2008.12.034.","journal-title":"Am J Kidney Dis"},{"key":"2800_CR11","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/dc11-S062","volume":"34","author":"Diagnosis and classification of diabetes mellitus","year":"2011","unstructured":"Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34:S62\u20139. https:\/\/doi.org\/10.2337\/dc11-S062.","journal-title":"Diabetes Care"},{"key":"2800_CR12","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42:1235\u2013481. https:\/\/doi.org\/10.1038\/s41440-019-0284-9.","journal-title":"Hypertens Res"},{"key":"2800_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/kisup.2012.64","volume":"3","author":"GJ Decreased","year":"2013","unstructured":"Decreased GJ. Definition and classification of CKD. Kidney Int Suppl (2011). 2013;3:19\u201362. https:\/\/doi.org\/10.1038\/kisup.2012.64.","journal-title":"Kidney Int Suppl (2011)"},{"key":"2800_CR14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","volume":"149","author":"SS Khan","year":"2024","unstructured":"Khan SS, Matsushita K, Sang Y, Ballew SH, Grams ME, Surapaneni A, et al. Development and validation of the American heart association\u2019s PREVENT equations. Circulation. 2024;149:430\u201349. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.067626.","journal-title":"Circulation"},{"key":"2800_CR15","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105:S117\u2013314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018.","journal-title":"Kidney Int"},{"key":"2800_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jacasi.2024.12.003","volume":"5","author":"H Zhang","year":"2025","unstructured":"Zhang H, Hu Z, Wu J, Li Y, Jiang S, Jin L, et al. Prevalence of cardiovascular-kidney-metabolic syndrome stages among middle-aged and older adults in China. JACC Asia. 2025;5:393\u20135. https:\/\/doi.org\/10.1016\/j.jacasi.2024.12.003.","journal-title":"JACC Asia"},{"key":"2800_CR17","doi-asserted-by":"publisher","first-page":"e2025005","DOI":"10.4178\/epih.e2025005","volume":"47","author":"S-B Hong","year":"2025","unstructured":"Hong S-B, Kim J-E, Han SS, Shearer JJ, Joo J, Choi J-Y, et al. Prevalence of cardiovascular-kidney-metabolic syndrome in Korea: Korea national health and nutrition examination survey 2011\u20132021. Epidemiol Health. 2025;47:e2025005. https:\/\/doi.org\/10.4178\/epih.e2025005.","journal-title":"Epidemiol Health"},{"issue":"6","key":"2800_CR18","doi-asserted-by":"publisher","first-page":"1004629","DOI":"10.1371\/journal.pmed.1004629","volume":"22","author":"M-K Tsai","year":"2025","unstructured":"Tsai M-K, Kao JT-W, Wong C-S, Liao C-T, Lo W-C, Chien K-L, et al. Cardiovascular\u2013kidney\u2013metabolic syndrome and all-cause and cardiovascular mortality: a retrospective cohort study. PLoS Med. 2025;22(6):1004629.","journal-title":"PLoS Med"},{"key":"2800_CR19","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","volume":"74","author":"MJ Sarnak","year":"2019","unstructured":"Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, et al. Chronic kidney disease and coronary artery disease. J Am Coll Cardiol. 2019;74:1823\u201338. https:\/\/doi.org\/10.1016\/j.jacc.2019.08.1017.","journal-title":"J Am Coll Cardiol"},{"key":"2800_CR20","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/ki.2010.550","volume":"79","author":"BC Astor","year":"2011","unstructured":"Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease: a collaborative meta-analysis of kidney disease population cohorts. Kidney Int. 2011;79:1331\u201340. https:\/\/doi.org\/10.1038\/ki.2010.550.","journal-title":"Kidney Int"},{"key":"2800_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/ki.2010.531","volume":"80","author":"RT Gansevoort","year":"2011","unstructured":"Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes: a collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80:93\u2013104. https:\/\/doi.org\/10.1038\/ki.2010.531.","journal-title":"Kidney Int"},{"key":"2800_CR22","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","volume":"3","author":"K Matsushita","year":"2015","unstructured":"Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, Guallar E, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015;3:514\u201325. https:\/\/doi.org\/10.1016\/S2213-8587(15)00040-6.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2800_CR23","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296\u2013305. https:\/\/doi.org\/10.1056\/NEJMoa041031.","journal-title":"N Engl J Med"},{"key":"2800_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/0886022X.2025.2468741","volume":"47","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Liu Y, Wu L, Zhang Y, Wen H, Hu J, et al. Causal insights into major risk factors for diabetic kidney disease: a comprehensive meta-analysis and Mendelian randomization study. Ren Fail. 2025;47:1\u201310. https:\/\/doi.org\/10.1080\/0886022X.2025.2468741.","journal-title":"Ren Fail"},{"key":"2800_CR25","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jacasi.2025.04.007","volume":"5","author":"C Zheng","year":"2025","unstructured":"Zheng C, Cai A, Sun M, Wang X, Song Q, Pei X, et al. Prevalence and mortality of cardiovascular-kidney-metabolic syndrome in China. JACC Asia. 2025;5:898\u2013910. https:\/\/doi.org\/10.1016\/j.jacasi.2025.04.007.","journal-title":"JACC Asia"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02800-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02800-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02800-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T08:11:45Z","timestamp":1772266305000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02800-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2800"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02800-x","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"12 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}